Get the Stockscreener App
1.95
18.07%
-0.43
Nls Pharmaceutics Ltd Stock (NLSP) Forecast
The Nls Pharmaceutics Ltd (NLSP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.2017, representing a -89.66% decrease from the current price of $1.95. The highest analyst price target is $0.1619, and the lowest is $0.2415.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NLSP Price Target
Average 0.859
(-55.95% Downside)
Is Nls Pharmaceutics Ltd (NLSP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.16 | Neutral |
| STOCH(9,6) | 26.10 | Neutral |
| STOCHRSI(14) | 60.39 | Neutral |
| MACD(12,26) | -0.4559 | Buy |
| ADX(14) | 23.28 | Neutral |
| William %R | -85.33 | Buy |
| CCI(14) | -14.59 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.99
Sell
|
2.1258
Sell
|
| MA20 |
2.503
Sell
|
2.4431
Sell
|
| MA50 |
3.4582
Sell
|
3.3406
Sell
|
| MA100 |
4.8113
Sell
|
4.6188
Sell
|
| MA200 |
5.9547
Sell
|
8.3284
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NLSP could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on NLSP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.16 indicates that NLSP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.1 indicates that NLSP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 60.39 indicates that NLSP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.28 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -14.59 indicates that NLSP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NLSP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nls Pharmaceutics Ltd financial reports and earnings history, Nls Pharmaceutics Ltd (NLSP) stock could reach $2.6054 by 2030, $11.16 by 2040 and $1.317 by 2050. See the projected annual prices until 2050 of the Nls Pharmaceutics Ltd stock below:
- Nls Pharmaceutics Ltd (NLSP) is expected to reach an average price of $0.693 in 2035, with a high prediction of $0.8324 and a low estimate of $0.7315. This indicates an $-64.46% rise from the last recorded price of $1.95.
- Nls Pharmaceutics Ltd (NLSP) stock is projected to chart a bullish course in 2040, with an average price target of $11.04, representing an $466.37% surge from its current level. The forecast ranges from a conservative $11.16 to a sky-high $11.16.
- Our analysts predict Nls Pharmaceutics Ltd (NLSP) to jump 228.94% by 2045, soaring from $6.5643 to an average price of $6.4143, potentially reaching $6.6931. While $6.5643 is the low estimate, the potential upside is significant.
- Nls Pharmaceutics Ltd (NLSP) stock is expected to climb by 2050, reaching an average of $0.9936, a $-49.04% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.317 and $1.0029, respectively, highlighting the market's uncertainty.
Nls Pharmaceutics Ltd Stock (NLSP) Year by Year Forecast
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2025
Nls Pharmaceutics Ltd Stock (NLSP) is expected to reach an average price of $0.859 in 2025, with a high prediction of $1.4764 and a low estimate of $0.2415. This indicates an -55.95% fall from the last recorded price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.2353 | $0.2415 | $0.1619 | -87.94% |
| February, 2025 | $0.4689 | $0.2687 | $0.3089 | -75.96% |
| March, 2025 | $0.5225 | $0.6423 | $0.6092 | -73.21% |
| April, 2025 | $1.3594 | $1.2259 | $1.1526 | -30.28% |
| May, 2025 | $1.563 | $1.3528 | $1.4453 | -19.84% |
| June, 2025 | $1.1366 | $1.3866 | $1.4764 | -41.71% |
| July, 2025 | $1.0136 | $1.0071 | $1.0934 | -48.02% |
| August, 2025 | $1.0072 | $0.8538 | $0.8138 | -48.35% |
| September, 2025 | $1.4809 | $1.164 | $1.182 | -24.06% |
| October, 2025 | $1.3576 | $1.4512 | $1.381 | -30.38% |
| November, 2025 | $1.3842 | $1.4487 | $1.3246 | -29.01% |
| December, 2025 | $1.5186 | $1.3616 | $1.4285 | -22.12% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2026
The predicted value for Nls Pharmaceutics Ltd (NLSP) in 2026 is set at an average of $0.7353. Estimates vary from a peak of $1.4618 to a trough of $0.00882, indicating an -62.29% surge from the present price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.3136 | $1.362 | $1.4618 | -32.64% |
| February, 2026 | $0.8559 | $0.9432 | $1.2554 | -56.11% |
| March, 2026 | $1.1692 | $0.909 | $0.9954 | -40.04% |
| April, 2026 | $1.1238 | $1.1494 | $1.0828 | -42.37% |
| May, 2026 | $0.6949 | $0.7596 | $0.8996 | -64.36% |
| June, 2026 | $0.1834 | $0.4533 | $0.5132 | -90.60% |
| July, 2026 | $0.0904 | $0.00982 | $0.4398 | -95.37% |
| August, 2026 | $0.076 | $0.00882 | $0.146 | -96.10% |
| September, 2026 | $0.0215 | $0.0274 | $0.4858 | -98.90% |
| October, 2026 | $0.3454 | $0.0356 | $0.4054 | -82.29% |
| November, 2026 | $0.0318 | $0.0632 | $0.392 | -98.37% |
| December, 2026 | $0.0649 | $0.045 | $0.0484 | -96.67% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nls Pharmaceutics Ltd (NLSP) is $0.2775, with a high forecast of $0.5546 and a low forecast of $0.000261. This indicates an -85.77% decrease from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.06 | $0.0234 | $0.5546 | -96.93% |
| February, 2027 | $0.00245 | $0.0484 | $0.2244 | -99.87% |
| March, 2027 | $0.3807 | $0.00405 | $0.3907 | -80.48% |
| April, 2027 | $0.0429 | $0.0105 | $0.4123 | -97.80% |
| May, 2027 | $0.0135 | $0.000261 | $0.3053 | -99.31% |
| June, 2027 | $0.1933 | $0.0433 | $0.099 | -90.09% |
| July, 2027 | $0.0471 | $0.1103 | $0.1667 | -97.58% |
| August, 2027 | $0.0593 | $0.00428 | $0.1227 | -96.96% |
| September, 2027 | $0.0923 | $0.00402 | $0.1223 | -95.27% |
| October, 2027 | $0.0463 | $0.0321 | $0.1589 | -97.63% |
| November, 2027 | $0.0649 | $0.00189 | $0.1201 | -96.67% |
| December, 2027 | $0.0222 | $0.0315 | $0.0467 | -98.86% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2028
In 2028, Nls Pharmaceutics Ltd (NLSP) is projected to reach an average price of $1.8348, with a high projection of $3.6553 and a low estimate of $0.0143. This indicates an -5.91% fall from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.7058 | $0.0143 | $2.9458 | +90.04% |
| February, 2028 | $2.663 | $2.3762 | $3.3826 | +36.56% |
| March, 2028 | $2.697 | $2.4766 | $2.617 | +38.31% |
| April, 2028 | $2.6842 | $2.839 | $2.6744 | +37.65% |
| May, 2028 | $2.7182 | $2.741 | $2.6683 | +39.39% |
| June, 2028 | $2.7654 | $2.815 | $2.7018 | +41.81% |
| July, 2028 | $3.3425 | $3.0021 | $3.1222 | +71.41% |
| August, 2028 | $2.7765 | $3.0015 | $3.1961 | +42.39% |
| September, 2028 | $2.9737 | $2.9931 | $2.8637 | +52.50% |
| October, 2028 | $3.1109 | $2.9373 | $2.9209 | +59.53% |
| November, 2028 | $3.0749 | $3.0877 | $3.1782 | +57.69% |
| December, 2028 | $3.6321 | $3.7321 | $3.6553 | +86.26% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2029
The 2029 price forecast for Nls Pharmaceutics Ltd Stock (NLSP) is $3.2554 on average, with a high prediction of $3.8629 and a low estimate of $2.648. This represents an +66.95% increase from the previous price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.9661 | $3.8025 | $3.8484 | +103.39% |
| February, 2029 | $3.4733 | $3.7233 | $3.8629 | +78.12% |
| March, 2029 | $3.1705 | $3.2774 | $3.4001 | +62.59% |
| April, 2029 | $3.0477 | $3.0577 | $3.0177 | +56.29% |
| May, 2029 | $3.6018 | $3.2445 | $3.3029 | +84.71% |
| June, 2029 | $3.4288 | $3.5288 | $3.4621 | +75.84% |
| July, 2029 | $3.366 | $3.4699 | $3.3292 | +72.62% |
| August, 2029 | $3.379 | $3.2832 | $3.3197 | +73.28% |
| September, 2029 | $3.1802 | $3.2572 | $3.3336 | +63.09% |
| October, 2029 | $2.6115 | $2.6988 | $3.0608 | +33.92% |
| November, 2029 | $2.8584 | $2.648 | $2.6846 | +46.58% |
| December, 2029 | $2.7028 | $2.7806 | $2.7554 | +38.60% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2030
Nls Pharmaceutics Ltd Stock (NLSP) is expected to reach an average price of $1.632 in 2030, with a high forecast of $2.6054 and a low forecast of $0.6587. This signifies an -16.31% decrease from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.2347 | $2.2994 | $2.6054 | +14.60% |
| February, 2030 | $1.6568 | $1.9267 | $2.0364 | -15.04% |
| March, 2030 | $1.4007 | $1.424 | $1.2141 | -28.17% |
| April, 2030 | $1.2812 | $1.385 | $1.3008 | -34.30% |
| May, 2030 | $1.0151 | $1.0651 | $1.1848 | -47.94% |
| June, 2030 | $0.8223 | $0.9803 | $0.9719 | -57.83% |
| July, 2030 | $1.0763 | $0.8991 | $1.0463 | -44.80% |
| August, 2030 | $1.1535 | $1.1199 | $1.0467 | -40.85% |
| September, 2030 | $0.9806 | $0.9987 | $1.0303 | -49.71% |
| October, 2030 | $0.8948 | $0.9573 | $0.9843 | -54.11% |
| November, 2030 | $0.6319 | $0.8219 | $0.8383 | -67.60% |
| December, 2030 | $0.7491 | $0.6587 | $0.6523 | -61.59% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):